Dimensional Fund Advisors LP Phathom Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

  • $418 Billion
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$6.2 - $15.5 $456,623 - $1.14 Million
-73,649 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$11.55 - $20.06 $145,633 - $252,936
12,609 Added 20.66%
73,649 $1 Million
Q4 2021

Feb 09, 2022
BUY
$17.83 - $33.15 $386,304 - $718,227
21,666 Added 55.03%
61,040 $1.2 Million
Q3 2021

Nov 12, 2021
BUY
$30.69 - $36.83 $1.21 Million - $1.45 Million
39,374 New
39,374 $1.26 Million

Others Institutions Holding PHAT

# of Institutions
138
Shares Held
60.3M
Call Options Held
1.35M
Put Options Held
1.19M
View Full List

About Phathom Pharmaceuticals, Inc.

PHAT Quotes by TradingView
  • Ticker PHAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,175,200
  • Market Cap $559M
  • Description
  • Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...
More about PHAT
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email